Cite

HARVARD Citation

    Cacoub, P. et al. (2008). Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?. Annals of the rheumatic diseases. 67 (3), pp. 283-287. [Online]. 
  
Back to record